nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—F12—Intrinsic Pathway—GP1BB—polycystic ovary syndrome	0.0849	0.169	CbGpPWpGaD
Ethanolamine Oleate—F12—Formation of Fibrin Clot (Clotting Cascade)—GP1BB—polycystic ovary syndrome	0.0573	0.114	CbGpPWpGaD
Ethanolamine Oleate—FABP4—embryo—polycystic ovary syndrome	0.04	0.0806	CbGeAlD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—CPB2—polycystic ovary syndrome	0.0366	0.0726	CbGpPWpGaD
Ethanolamine Oleate—F12—uterus—polycystic ovary syndrome	0.0339	0.0683	CbGeAlD
Ethanolamine Oleate—F12—pituitary gland—polycystic ovary syndrome	0.0333	0.0671	CbGeAlD
Ethanolamine Oleate—F12—adipose tissue—polycystic ovary syndrome	0.0332	0.0668	CbGeAlD
Ethanolamine Oleate—FABP4—adrenal cortex—polycystic ovary syndrome	0.0328	0.066	CbGeAlD
Ethanolamine Oleate—F12—Blood Clotting Cascade—PLAT—polycystic ovary syndrome	0.0298	0.0592	CbGpPWpGaD
Ethanolamine Oleate—FABP5—uterus—polycystic ovary syndrome	0.0288	0.0581	CbGeAlD
Ethanolamine Oleate—FABP5—adipose tissue—polycystic ovary syndrome	0.0282	0.0568	CbGeAlD
Ethanolamine Oleate—F12—vagina—polycystic ovary syndrome	0.0276	0.0555	CbGeAlD
Ethanolamine Oleate—FABP4—adipose tissue—polycystic ovary syndrome	0.0264	0.0531	CbGeAlD
Ethanolamine Oleate—F12—endocrine gland—polycystic ovary syndrome	0.0258	0.052	CbGeAlD
Ethanolamine Oleate—FABP5—adrenal gland—polycystic ovary syndrome	0.0253	0.051	CbGeAlD
Ethanolamine Oleate—FABP4—adrenal gland—polycystic ovary syndrome	0.0237	0.0477	CbGeAlD
Ethanolamine Oleate—FABP5—female gonad—polycystic ovary syndrome	0.0236	0.0475	CbGeAlD
Ethanolamine Oleate—FABP4—female gonad—polycystic ovary syndrome	0.0221	0.0444	CbGeAlD
Ethanolamine Oleate—FABP5—endocrine gland—polycystic ovary syndrome	0.0219	0.0442	CbGeAlD
Ethanolamine Oleate—FABP4—vagina—polycystic ovary syndrome	0.0219	0.0442	CbGeAlD
Ethanolamine Oleate—FABP4—endocrine gland—polycystic ovary syndrome	0.0205	0.0413	CbGeAlD
Ethanolamine Oleate—CYP2E1—urine—polycystic ovary syndrome	0.0203	0.0408	CbGeAlD
Ethanolamine Oleate—F12—Blood Clotting Cascade—SERPINE1—polycystic ovary syndrome	0.0141	0.0279	CbGpPWpGaD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—PLAT—polycystic ovary syndrome	0.0135	0.0269	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.0097	0.0193	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.0096	0.0191	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—polycystic ovary syndrome	0.00926	0.0184	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—SLC2A4—polycystic ovary syndrome	0.00875	0.0174	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—NCOR1—polycystic ovary syndrome	0.00699	0.0139	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.00698	0.0139	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—GP1BB—polycystic ovary syndrome	0.00691	0.0137	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CDH15—polycystic ovary syndrome	0.00655	0.013	CbGpPWpGaD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—SERPINE1—polycystic ovary syndrome	0.00639	0.0127	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00629	0.0125	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—LEP—polycystic ovary syndrome	0.00575	0.0114	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00534	0.0106	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—PPARG—polycystic ovary syndrome	0.00501	0.00995	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00498	0.00988	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00498	0.00988	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PDE3B—polycystic ovary syndrome	0.00464	0.00921	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00417	0.00828	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00397	0.00788	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00395	0.00785	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00393	0.0078	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00387	0.0078	CbGeAlD
Ethanolamine Oleate—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—polycystic ovary syndrome	0.00379	0.00752	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00377	0.00749	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00336	0.00677	CbGeAlD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00321	0.00637	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NMNAT3—polycystic ovary syndrome	0.00307	0.00608	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00292	0.0058	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00286	0.00567	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—LPCAT2—polycystic ovary syndrome	0.0028	0.00557	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SUOX—polycystic ovary syndrome	0.0028	0.00557	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00277	0.00549	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00261	0.00517	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00257	0.00509	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00255	0.00506	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PLAT—polycystic ovary syndrome	0.00243	0.00482	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00238	0.00472	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—IL6—polycystic ovary syndrome	0.00232	0.0046	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00226	0.00448	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TEAD2—polycystic ovary syndrome	0.00222	0.0044	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00222	0.0044	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Vitamin A and Carotenoid Metabolism—RBP4—polycystic ovary syndrome	0.00221	0.0044	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00215	0.00426	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00213	0.00423	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—DLG4—polycystic ovary syndrome	0.00211	0.00419	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.0021	0.00416	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00209	0.00416	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00206	0.0041	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00198	0.00392	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—GNAS—polycystic ovary syndrome	0.00186	0.0037	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PNPLA2—polycystic ovary syndrome	0.00186	0.00369	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00176	0.00349	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—STAR—polycystic ovary syndrome	0.00168	0.00333	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00166	0.0033	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00158	0.00314	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.0015	0.00298	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HMMR—polycystic ovary syndrome	0.0015	0.00297	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00148	0.00294	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HSD3B1—polycystic ovary syndrome	0.00143	0.00283	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00141	0.0028	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00141	0.00279	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.0014	0.00277	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00138	0.00274	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00137	0.00271	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00134	0.00266	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—LHB—polycystic ovary syndrome	0.0013	0.00259	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—LEP—polycystic ovary syndrome	0.0013	0.00258	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HSD3B2—polycystic ovary syndrome	0.00127	0.00253	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00123	0.00245	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00122	0.00242	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—IGF1—polycystic ovary syndrome	0.00121	0.00239	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—AKT2—polycystic ovary syndrome	0.00121	0.00239	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00115	0.00227	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SULT2A1—polycystic ovary syndrome	0.00113	0.00225	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—PPARG—polycystic ovary syndrome	0.00113	0.00225	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00113	0.00225	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—INS—polycystic ovary syndrome	0.00111	0.00221	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00111	0.00219	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.0011	0.00219	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—RRM2—polycystic ovary syndrome	0.0011	0.00218	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00109	0.00217	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT2—polycystic ovary syndrome	0.00107	0.00213	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00106	0.00211	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—YAP1—polycystic ovary syndrome	0.00106	0.0021	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NAMPT—polycystic ovary syndrome	0.00102	0.00202	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00101	0.00201	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP11A1—polycystic ovary syndrome	0.001	0.00199	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000998	0.00198	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000949	0.00188	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000934	0.00185	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000896	0.00178	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000891	0.00177	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000879	0.00175	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TH—polycystic ovary syndrome	0.000808	0.0016	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—VEGFA—polycystic ovary syndrome	0.000788	0.00156	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000786	0.00156	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000783	0.00155	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000739	0.00147	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00073	0.00145	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000722	0.00143	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00072	0.00143	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000702	0.00139	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000664	0.00132	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GNAS—polycystic ovary syndrome	0.00066	0.00131	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000647	0.00128	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000638	0.00127	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NCOR1—polycystic ovary syndrome	0.000629	0.00125	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000603	0.0012	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000601	0.00119	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000596	0.00118	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000593	0.00118	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—MTHFR—polycystic ovary syndrome	0.000556	0.0011	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000539	0.00107	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—IL6—polycystic ovary syndrome	0.000485	0.000964	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000476	0.000945	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000469	0.000932	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PPARG—polycystic ovary syndrome	0.00045	0.000894	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—POMC—polycystic ovary syndrome	0.000444	0.000882	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—INS—polycystic ovary syndrome	0.000442	0.000877	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000384	0.000762	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000378	0.000751	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000337	0.00067	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000309	0.000613	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000309	0.000613	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000287	0.00057	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.000286	0.000568	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000244	0.000484	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000244	0.000484	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000204	0.000406	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000194	0.000385	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000185	0.000367	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000165	0.000327	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000157	0.000312	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000143	0.000285	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00014	0.000278	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000136	0.000269	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000125	0.000248	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000121	0.00024	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000117	0.000231	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000112	0.000222	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000111	0.00022	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000104	0.000207	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000103	0.000204	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TH—polycystic ovary syndrome	8.9e-05	0.000177	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	8.66e-05	0.000172	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	8.14e-05	0.000162	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	7.27e-05	0.000144	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	6.92e-05	0.000137	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	6.56e-05	0.00013	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	6.12e-05	0.000121	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	4.96e-05	9.85e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	4.89e-05	9.71e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—INS—polycystic ovary syndrome	4.86e-05	9.66e-05	CbGpPWpGaD
